Exelixis Inc (NASDAQ: EXEL) has seen a rise in its stock price by 0.76 in relation to its previous close of 36.85. However, the company has experienced a 6.09% gain in its stock price over the last five trading sessions. zacks.com reported 2025-02-24 that Investors with an interest in Medical – Biomedical and Genetics stocks have likely encountered both Exelixis (EXEL) and Techne (TECH). But which of these two stocks is more attractive to value investors?
Is It Worth Investing in Exelixis Inc (NASDAQ: EXEL) Right Now?
The price-to-earnings ratio for Exelixis Inc (NASDAQ: EXEL) is above average at 20.95x, Company’s 36-month beta value is 0.59.Analysts have differing opinions on the stock, with 8 analysts rating it as a “buy,” 5 as “overweight,” 9 as “hold,” and 0 as “sell.”
The public float for EXEL is 272.33M, and currently, short sellers hold a 4.81% ratio of that floaft. The average trading volume of EXEL on February 25, 2025 was 2.33M shares.
EXEL’s Market Performance
The stock of Exelixis Inc (EXEL) has seen a 6.09% increase in the past week, with a 8.79% rise in the past month, and a 7.90% gain in the past quarter. The volatility ratio for the week is 3.32%, and the volatility levels for the past 30 days are at 3.14% for EXEL. The simple moving average for the past 20 days is 9.53% for EXEL’s stock, with a 31.06% simple moving average for the past 200 days.
Analysts’ Opinion of EXEL
Morgan Stanley, on the other hand, stated in their research note that they expect to see EXEL reach a price target of $40, previously predicting the price at $30. The rating they have provided for EXEL stocks is “Overweight” according to the report published on January 27th, 2025.
EXEL Trading at 8.25% from the 50-Day Moving Average
After a stumble in the market that brought EXEL to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -1.22% of loss for the given period.
Volatility was left at 3.14%, however, over the last 30 days, the volatility rate increased by 3.32%, as shares surge +14.67% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +5.57% upper at present.
During the last 5 trading sessions, EXEL rose by +6.09%, which changed the moving average for the period of 200-days by +69.54% in comparison to the 20-day moving average, which settled at $33.90. In addition, Exelixis Inc saw 11.50% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at EXEL starting from Haley Patrick J., who proposed sale 52,636 shares at the price of $36.84 back on Feb 24 ’25. After this action, Haley Patrick J. now owns shares of Exelixis Inc, valued at $1,939,213 using the latest closing price.
Aftab Dana, the Officer of Exelixis Inc, proposed sale 26,987 shares at $36.75 during a trade that took place back on Feb 24 ’25, which means that Aftab Dana is holding shares at $991,772 based on the most recent closing price.
Stock Fundamentals for EXEL
Current profitability levels for the company are sitting at:
- 0.28 for the present operating margin
- 0.96 for the gross margin
The net margin for Exelixis Inc stands at 0.24. The total capital return value is set at 0.24. Equity return is now at value 23.13, with 17.42 for asset returns.
Based on Exelixis Inc (EXEL), the company’s capital structure generated 0.08 points at debt to capital in total, while cash flow to debt ratio is standing at 3.67.
Currently, EBITDA for the company is 718.75 million with net debt to EBITDA at -0.04. When we switch over and look at the enterprise to sales, we see a ratio of 4.78. The receivables turnover for the company is 8.17for trailing twelve months and the total asset turnover is 0.74. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.63.
Conclusion
In a nutshell, Exelixis Inc (EXEL) has experienced a better performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
